Viteava Pharmaceuticals has announced the execution of an exclusive worldwide license to an intellectual property portfolio claiming composition of matter and/or methods of use of novel analogs and derivatives of the green tea flavonoid, ...
Tags: exclusive worldwide license, EGCG, Viteava Pharmaceuticals